Augustine Titto, Maitra Radhashree, Goel Sanjay
Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, USA.
Genes Cancer. 2017 May;8(5-6):550-558. doi: 10.18632/genesandcancer.140.
Length of the telomere (TL), a structure at the tip of chromosome that protects and ensures stability, is determined by multi-protein complexes such as telosome/shelterin and telomerase. Earlier studies from our laboratory show that longer TL has potential to be positive predictive biomarker of clinical outcome to anti-epidermal growth factor receptor (EGFR) monoclonal antibody therapy in patients with KRAS WT metastatic colorectal cancer. Although there is extensive literature suggesting the role of shelterin and telomerase, not much literature exists that describes the role of EGFR and KRAS pathway in regulating TL. This detailed review focuses on an insight into various components, including proteins, enzymes and transcription factors, interlinking between EGFR pathways and telomerase that regulate TL.
端粒长度(TL)是染色体末端的一种结构,具有保护和确保稳定性的作用,它由端粒体/端粒保护蛋白复合体和端粒酶等多种蛋白质复合体决定。我们实验室早期的研究表明,较长的端粒长度有可能成为KRAS野生型转移性结直肠癌患者接受抗表皮生长因子受体(EGFR)单克隆抗体治疗临床结局的阳性预测生物标志物。尽管有大量文献表明端粒保护蛋白复合体和端粒酶的作用,但描述EGFR和KRAS通路在调节端粒长度中作用的文献却不多。这篇详细的综述着重深入探讨各种成分,包括蛋白质、酶和转录因子,它们在调节端粒长度的EGFR通路和端粒酶之间建立联系。